Literature DB >> 6377438

Current trends in immunodiagnosis of candidiasis and aspergillosis.

L de Repentigny, E Reiss.   

Abstract

The methods and reagents currently used for the immunodiagnosis of aspergillosis and candidiasis are reviewed. Problems associated with these techniques and approaches to resolving these problems are discussed. Latex agglutination and precipitin tests are used for detection of antibody in immunocompetent hosts. However, these tests are apparently inadequate when applied to the diagnosis of systemic candidiasis in compromised hosts. Enzyme immunoassays ( EIAs ) and radioimmunoassays (RIAs) can be used to detect antibodies in immunocompetent and compromised patients, but their value is limited because antibodies to the Candida species are detectable in healthy as well as colonized and infected patients. EIAs and RIAs are, however, promising for detection of antigenemia in patients with aspergillosis or candidiasis, and gas-liquid chromatography has been developed for the quantitation of serum arabinitol and mannose in candidiasis. Antigens of the Aspergillus and Candida species may circulate in patients' sera in the form of immune complexes. These may readily be dissociated by a variety of methods to permit the detection of diagnostically important antigens. Studies are being carried out to increase the sensitivity and reliability of these tests through the use of monoclonal antibodies and purified, clinically relevant antigens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6377438     DOI: 10.1093/clinids/6.3.301

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  48 in total

1.  Early detection and identification of commonly encountered Candida species from simulated blood cultures by using a real-time PCR-based assay.

Authors:  Younes Maaroufi; Jean-Marc De Bruyne; Valérie Duchateau; Aspasia Georgala; Françoise Crokaert
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

2.  Rapid diagnosis of bacteremia in adults using acridine orange stained buffy coat smears.

Authors:  M Miller; J Mendelson
Journal:  Can J Infect Dis       Date:  1990

Review 3.  Immunologic tests in the diagnosis of pulmonary infection.

Authors:  E Goldstein; J Koo
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

4.  Semiquantitative polymerase chain reaction enzyme immunoassay for diagnosis of disseminated candidiasis.

Authors:  J P Burnie; N Golbang; R C Matthews
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

5.  Detection of the 43,000-molecular-weight glycoprotein in sera of patients with paracoccidioidomycosis.

Authors:  M J Mendes-Giannini; J P Bueno; M A Shikanai-Yasuda; A W Ferreira; A Masuda
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

6.  Risk factors for candidemia in cancer patients: a case-control study.

Authors:  A Karabinis; C Hill; B Leclercq; C Tancrède; D Baume; A Andremont
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

7.  Detection of Candida antigenuria in disseminated candidiasis by immunoblotting.

Authors:  R P Ferreira; B Yu; Y Niki; D Armstrong
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

8.  Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis.

Authors:  M E Bougnoux; C Hill; D Moissenet; M Feuilhade de Chauvin; M Bonnay; I Vicens-Sprauel; F Pietri; M McNeil; L Kaufman; J Dupouy-Camet
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

9.  Candida detection system (CAND-TEC) to differentiate between Candida albicans colonization and disease.

Authors:  J C Fung; S T Donta; R C Tilton
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

10.  Evaluation of enzyme immunoassay for Candida cytoplasmic antigens in neutropenic cancer patients.

Authors:  M Morhart; R Rennie; B Ziola; E Bow; T J Louie
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.